Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
   
 
                                                                                                
      
 
About Us
MISSION STATEMENT
St. Louis College of Pharmacy at the University of Health Sciences and Pharmacy (UHSP) in St. Louis continuing education provides learning opportunities to meet licensure requirements and professional development needs of pharmacy practitioners in a variety of practice settings throughout the region, including alumni, preceptors, and residents, through flexible continuing pharmacy education (CPE). CPE activities are delivered internally and collaboratively through regional joint providership agreements.
 
CONTINUING PHARMACY EDUCATION ADMINISTRATOR
Questions about CE? Please contact CE@uhsp.edu for assistance.
 

 
 
 
 
 
 
 
 
 

POLICY UPDATE & FAQ
 
On June 1, 2019, policies surrounding adjustments and corrections to CE credit as well as to registrations became effective. To learn more about these policies, or to read answers to other commonly asked questions, check out the FAQ page. Still don't see what you are looking for? Contact us.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
              

 

 
 
Fall 2023 Resident Seminars

Join us on UHSP's campus for our Fall 2023 Resident Seminar Series!

Participants can choose from a variety of 45-minute live or virtual sessions, prepared by PGY1 and PGY2 pharmacy residents from the St. Louis metropolitan area. Pharmacists can earn a maximum of 2.25 of continuing pharmacy education credit per session, for a total of 6.75 CEUs for all three sessions.                                                                      

Seminar Dates:  

  • Tuesday, October 10, 2023 from 1:00pm to 3:35pm

 
Distance CE Activities

Expanded Role of Rivaroxaban in Patients with Diabetes and Coronary Artery Disease: Patients with diabetes mellitus (DM) are more likely to have cardiovascular (CV) disease and an increased thrombotic risk; therefore, aggressive management to prevent CV events is crucial. Join Dr. Ashley Lopez for a 45-minute presentation as she addresses emerging evidence on the potential use of dual pathway antithrombotic therapy with aspirin in combination with reduced-dose anticoagulant and stratify the clinical benefit in patients with diabetes mellitus and coronary artery disease.

To learn more about Expanded Role of Rivaroxaban in Patients with Diabetes and Coronary Artery Disease, please click below (if you are an alumnus, please send an email to alumni@uhsp.edu to receive a code to participate in this activity free of charge).

The Utilization of Medications that Augment the Nitric Oxide Pathway in Heart Failure Patients: Join Dr. Brooke Jacobson as she examine the role of medications that augment the nitric oxide pathway in patients with heart failure with reduced ejection fraction. This presentation will begin by describing the background, etiology, and prevalence of heart failure followed by the pathophysiology. The pathophysiology in this presentation will specifically cover how the nitric oxide pathway is altered in patients with heart failure. Current guideline recommendations for optimizing heart failure medications will be reviewed. The presentation will then look at literature available for the nitric oxide augmenting agents. The trials that study the effectiveness of hydralazine/isosorbide (V-HeFT trials and the A-HeFT trial) will be reviewed and analyzed as well as the VICTORIA trial. The VICTORIA trial evaluates the efficacy of the newest agent in this drug class- vericiguat. The presentation will conclude with an evaluation of how these agents should be used in current practice. A treatment algorithm will be included to guide the decision on who should receive these agents.

To learn more about Just Say NO to HFrEF: The Utilization of Medications that Augment the Nitric Oxide Pathway in Patients with Heart Failure, please click below (if you are an alumnus, please send an email to alumni@uhsp.edu to receive a code to participate in this activity free of charge).

A Closer Look at Episodic Migraine Prevention: Join Dr. Nicole Short for this 45-minute presentation where she discusses the characteristics of episodic migraine followed by an explanation of the mechanism of calcitonin gene-related peptide (CGRP) antagonists. An overview of current American Academy of Neurology recommendations and the European Headache Fede

Upcoming | Past
 
Programs Date Hours Flyer
No Records Found.
 
Programs Release Date Expiration Date Flyer Hours
Expanded Role of Rivaroxaban in Patients with Diabetes and Coronary Artery Disease 02/04/2022 02/04/2025 N.A. 0.75
Just Say NO to HFrEF: The Utilization of Medications that Augment the Nitric Oxide Pathway in Patients with Heart Failure 02/01/2022 02/01/2025 N.A. 0.75
A Closer Look at Episodic Migraine Prevention 01/24/2022 01/24/2025 N.A. 0.75
Two's Company, Three's a Crowd: Optimizing Therapy for People Living with HIV 01/21/2022 01/21/2025 N.A. 0.75
Beta Blockade in Sepsis 01/11/2022 01/11/2025 N.A. 0.75
Oral Antibiotics for Step-Down Therapy in Uncomplicated Gram-Negative Bacteremia 01/07/2022 01/07/2025 N.A. 0.75
Medical Cannabis for Pharmacists 09/28/2021 09/28/2024 N.A. 1.00
Introduction to Biosimilars 03/05/2021 02/10/2024 N.A. 0.75
Antithrombotic Therapy Following Transcatheter Aortic Valve Replacement 02/22/2021 02/22/2024 N.A. 0.75
Emerging Targets for Multiple Myeloma: B-cell Maturation Antigen (BCMA) Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy 02/02/2021 02/02/2024 N.A. 0.75
Utility of Inhaled Nitric Oxide in Acute Pulmonary Embolism 02/12/2021 02/12/2024 N.A. 0.75
Darth Vapor: The JUUL of the Empire 11/12/2020 11/12/2023 N.A. 1.00
A Brief Update on the 2020 COPD Guidelines 08/18/2020 08/18/2023 N.A. 0.50
COVID-19: Treatment Options 04/20/2020 04/20/2023 N.A. 1.00
Heart Failure 04/23/2020 04/23/2023 N.A. 1.50
Hospice and Palliative Care: A Certificate Program for Pharmacists 07/21/2022 07/21/2025 N.A. 20.00
Preceptor Mini-Series 1: Preceptor Pharm Tools 01/30/2023 01/30/2026 Flyer 3.00
Preceptor Mini-Series 5: Change of Heart - An Interprofessional Mini-Series 01/30/2023 01/30/2026 N.A. 3.00